Panic and hypertension: Brothers in arms through 5-HT?

Journal of Psychopharmacology

Volumn 21, Issue 6, 2007, Pages 563-566

  Davies, S J ^a   Lowry, C A ^b   Nutt, D J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; IMIPRAMINE; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 2 RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

AGORAPHOBIA; ANXIETY DISORDER; AUTONOMIC DYSFUNCTION; AUTONOMIC NERVOUS SYSTEM; AWARENESS; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; BRAIN STEM; CATECHOLAMINE NERVE CELL; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; EDITORIAL; FACTORIAL ANALYSIS; HEART RATE VARIABILITY; HUMAN; HYPERTENSION; MAJOR DEPRESSION; MEDICAL LITERATURE; MEDICAL RESEARCH; NEUROANATOMY; NEUROCHEMISTRY; NEUROTRANSMISSION; NONHUMAN; PANIC; PRIORITY JOURNAL; REGRESSION ANALYSIS; SEROTONINERGIC NERVE CELL; SEROTONINERGIC SYSTEM; WHITE COAT HYPERTENSION;

ANIMALS; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; HUMANS; HYPERTENSION; NEURAL INHIBITION; NEURONS; PANIC DISORDER; PERIAQUEDUCTAL GRAY; RAPHE NUCLEI; SEROTONIN; SEROTONIN AGENTS;

EID: 34748837217     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881107082359     Document Type: Editorial

References (31)

1. Bago M., Dean C. (2001) Sympathoinhibition from ventrolateral periaqueductal gray mediated by 5-HT(1A) receptors in the RVLM. Am J Physiol Regul Integr Comp Physiol 280: R976 - R984
2. Bago M., Sprtel B.M., Dean C. (1999) Modulation of sympathetic nerve activity by microinjection of the 5-HT1A receptor agonist 8-OH-DPAT into the rostroventrolateral medulla. J Auton Nerv Syst 76: 127 - 134
3. Beckett S., Marsden C.A. (1997) The effect of central and systemic injection of the 5-HT1A receptor agonist 8-OHDPAT and the 5-HT1A receptor antagonist WAY100635 on periaqueductal grey-induced defence behaviour. J Psychopharmacol 11: 35 - 40
4. Bell C.C., Hildreth C.J., Jenkins E.J., Carter C. (1988) The relationship of isolated sleep paralysis and panic disorder to hypertension. J Natl Med Assoc 80: 289 - 294
5. Cechetto D.F., Saper C.B. (1987) Evidence for a viscerotopic sensory representation in the cortex and thalamus in the rat. J Comp Neurol 262: 27 - 45
6. Davies S J C, Ghahramani P., Jackson P.R., Noble T.W., Hardy P.G., Hippisley-Cox J., Yeo W.W., Ramsay L.E. (1999) Association of Panic Disorder and Panic Attacks with Hypertension. Am J Med 107: 310 - 316
7. Davies S J C, Jackson P.R., Ramsay L.E., Ghahramani P., Palmer R.L., Hippisley-Cox J. (2003) No evidence that panic attacks are associated with the white coat effect in hypertension. J Clin Hypertens 5: 145 - 152
8. Davies S J C, Hood S.D., Argyropoulos S.V., Morris K., Bell C., Witchel H.J., Jackson P.R., Nutt D.J., Potokar J.P. (2006 a) Depleting Serotonin enhances both cardiovascular and psychological stress reactivity in recovered patients with anxiety disorders. J Clin Psychopharm 26: 414 - 418
9. Davies S J C, Jackson P.R., Lewis G., Hood S.D., Nutt D.J. (2006 b) Panic attacks are more likely to include autonomic symptoms in patients with hypertension than in normotensives - a comparison of symptoms, and factor analysis. ECNP Workshop on Psychophamacology, Nice. 2006. European Neuropsychopharmacology 16: S94-S95
10. Esler M.D., Jennings G.L., Lambert G.W. (1988) Release of noradrenaline into the cerebrovascular circulation in patients with primary hypertension. J Hypertens Suppl 6: S494 - S496
11. Ferrier C., Jennings G.L., Eisenhofer G., Lambert G., Cox H.S., Kalff V., Kelly M., Esler M.D. (1993) Evidence for increased noradrenaline release from subcortical brain regions in essential hypertension. J Hypertens 11: 1217 - 1227
12. Glassman A.H., O'Connor C.M., Califf R.M., Swedberg K., Schwartz P., Bigger J.T. Jr, et al. (2002) Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 288: 701 - 709
13. Grassi G., Kiowski W. (2002) Is the autonomic dysfunction the missing link between panic disorder, hypertension and cardiovascular disease? J Hypertens 20: 2347 - 2349
14. Holstege G. (1995) The basic, somatic, and emotional components of the motor system in mammals. In Paxinos G (ed.) The rat nervous system, 2 nd ed. Academic Press, San Diego
15. Jacob C.A., Cabral A.H., Almeida L.P., Magierek V., Ramos P.L., Zanoveli J.M., Landeira-Fernandez J., Zangrossi H., Nogueira R.L. (2002) Chronic imipramine enhances 5-HT(1A) and 5-HT(2) receptors-mediated inhibition of panic-like behavior in the rat dorsal periaqueductal gray. Pharmacol Biochem Behav 72: 761 - 766
16. Johnson P.L., Lightman S.L., Lowry C.A. (2004) A functional subset of serotonergic neurons in the rat ventrolateral periaqueductal gray implicated in the inhibition of sympathoexcitation and panic. Ann N Y Acad Sci 1018: 58 - 64
17. Katon W. (1984) Panic disorder and somatization. Am J Med 77: 101 - 106
18. Katon W. (1986) Panic disorder: epidemiology, diagnosis, and treatment in primary care. J Clin Psychiatry 47 (Suppl. 10). 21 - 27
19. Keay K.A., Bandler R. (2001) Parallel circuits mediating distinct emotional coping reactions to different types of stress. Neurosci Biobehav Rev 25: 669 - 678
20. Kerman I.A., Shabrang C., Taylor L., Akil H., Watson S.J. (2006) Relationship of presympathetic-premotor neurons to the serotonergic transmitter system in the rat brainstem. J Comp Neurol 499: 882 - 896
21. Malizia A.L. (1999) What do brain imaging studies tell us about anxiety disorders? J Psychopharmacol 13: 372 - 378
22. Mann S.J. (2003) Neurogenic essential hypertension revisited: the case for increased clinical and research attention. Am J Hypertens 16: 881 - 888
23. Nogueira R.L., Graeff F.G. (1995) Role of 5-HT receptor subtypes in the modulation of dorsal periaqueductal gray generated aversion. Pharmacol Biochem Behav 52: 1 - 6
24. Noyes R., Clancy J., Hoenk P.R., Slymen D.J. (1978) Anxiety neurosis and physical illness. Compr Psychiatry 19: 407 - 413
25. Polyák J. (2001) How should we manage cardiovascular panic disorder accompanied by hypertension? J Hypertens 19 (Suppl. 2). S64 (Abstract)
26. Rasmussen A., Lunde M., Poulsen D.L., Sorensen K., Qvitzau S., Bech P. (2003) A double-blind, placebo-controlled study of sertraline in the prevention of depression in stroke patients. Psychosomatics 44: 216 - 221
27. Richerson G.B. (2004) Serotonergic neurons as carbon dioxide sensors that maintain homeostasis. Nat Rev Neurosci 5: 449 - 461
28. Shekhar A., Keim S.R. (1997) The circumventricular organs form a potential neural pathway for lactate sensitivity: implications for panic disorder. J Neurosci 17: 9726 - 9735
29. Weissman M.M., Markowitz J.S., Ouellette R., Greenwald S., Kahn J.P. (1990) Panic disorder and cardiovascular/ cerebrovascular problems: results from a community survey. Am J Psychiatry 147: 1504 - 1508
30. Wilkinson D.J., Thompson J.M., Lambert G.W., Jennings G.L., Schwarz R.G., Jefferys D., Turner A.G., Esler M.D. (1998) Sympathetic activity in patients with panic disorder at rest, under laboratory mental stress, and during panic attacks. Arch Gen Psychiatry 55: 511 - 520
31. Yeragani V.K., Jampala V.C., Sobelewski E., Kay J., Igel G. (1999) Effects of paroxetine on heart period variability in patients with panic disorder: a study of holter ECG records. Neuropsychobiology 40: 124 - 128